Vaccine Industry Retools Itself for Speed
Vaccine Manufacturing Moves toward Mass Customization
Key Trends in 2018 in the Biopharmaceutical Market
Interview with Nigel Darby, Advisor, GE Healthcare Life Sciences
Top 10 Best-Selling Cancer Drugs, Q1–Q3 2017
15% Year-Over-Year Growth, with Sales Set to More than Double by 2022
Epigenetic Drugs: Team Players in Combo Therapies
Scientists May Be Better Able to Destroy Tumors and Possibly Reverse CNS Decline
For full access to this article login to GEN Select now.
Promises, Promises, and Cell Lines
Life Sciences Researchers Talk About the Obvious Solution—Cell-Line Authentication—but They Fail To Implement It
- According to a 2013 report from the American Association for the Advancement of Science, $115 billion is spent annually in the United States on life science research. Fifty percent of this total is spent on preclinical research, half of which—$28 billion—is not reproducible. Irreproducibility causes delays and failures ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.